Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Larkin

Showing results (121-130 of 418) with videos related to

Pageof 42
Sort By:
Melanoma Research|October 2, 2015
Integrating first-line treatment options into clinical practice: what's new in advanced melanoma?Reinhard Dummer, Dirk Schadendorf, Paolo A Ascierto, et al.
BMJ Open|December 29, 2022
What is the impact of multimorbidity on out-of-pocket healthcare expenditure among community-dwelling older adults in Ireland? A cross-sectional studyJames Larkin, Brendan Walsh, Frank Moriarty, et al.
The Lancet. Oncology|December 4, 2018
Adjuvant melanoma therapy with new drugs: should physicians continue to focus on metastatic disease or use it earlier in primary melanoma?Jean Jacques Grob, Claus Garbe, Paolo Ascierto, et al.
Neuroprotection (Chichester, England)|June 29, 2026
Post-recanalization administration of rapamycin improves functional outcome and reduces infarct size in a rat model of ischemic strokeAnna M Schneider, Yvonne Couch, James Larkin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Metastatic mucinous tubular and spindle cell carcinoma of the kidney responding to sunitinibJames Larkin, Rosalie Fisher, Lisa Pickering, et al.
Pigment Cell & Melanoma Research|September 29, 2015
Extrinsic factors can mediate resistance to BRAF inhibition in central nervous system melanoma metastasesHeike Seifert, Eishu Hirata, Martin Gore, et al.
BMJ Open|September 4, 2025
Does online information about hormone replacement therapy (or menopause hormone therapy) reflect indications from the British National Formulary and guidance from the National Institute for Health and Care Excellence: a cross-sectional study of UK mediaMargaret McCartney, Rosa Morgan-Young, Frank Sullivan, et al.
Melanoma Research|April 11, 2015
The cost of ipilimumab toxicity: a single-centre analysisNadia Yousaf, Michael Davidson, Emily Goode, et al.
The Journal of Arthroplasty|December 11, 2012
Stiffness after total knee arthroplasty: does component alignment differ in knees requiring manipulation? A retrospective cohort study of 281 patientsPaul Harvie, James Larkin, Matt Scaddan, et al.
The Lancet. Oncology|August 1, 2012
Adjuvant nodal irradiation in melanomaMuhammad Khattak, Martin Gore, James Larkin, et al.
Pageof 42

Showing results (121-130 of 418) with videos related to

Sort By:
Pageof 42
Melanoma Research|October 2, 2015
Integrating first-line treatment options into clinical practice: what's new in advanced melanoma?Reinhard Dummer, Dirk Schadendorf, Paolo A Ascierto, et al.
BMJ Open|December 29, 2022
What is the impact of multimorbidity on out-of-pocket healthcare expenditure among community-dwelling older adults in Ireland? A cross-sectional studyJames Larkin, Brendan Walsh, Frank Moriarty, et al.
The Lancet. Oncology|December 4, 2018
Adjuvant melanoma therapy with new drugs: should physicians continue to focus on metastatic disease or use it earlier in primary melanoma?Jean Jacques Grob, Claus Garbe, Paolo Ascierto, et al.
Neuroprotection (Chichester, England)|June 29, 2026
Post-recanalization administration of rapamycin improves functional outcome and reduces infarct size in a rat model of ischemic strokeAnna M Schneider, Yvonne Couch, James Larkin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Metastatic mucinous tubular and spindle cell carcinoma of the kidney responding to sunitinibJames Larkin, Rosalie Fisher, Lisa Pickering, et al.
Pigment Cell & Melanoma Research|September 29, 2015
Extrinsic factors can mediate resistance to BRAF inhibition in central nervous system melanoma metastasesHeike Seifert, Eishu Hirata, Martin Gore, et al.
BMJ Open|September 4, 2025
Does online information about hormone replacement therapy (or menopause hormone therapy) reflect indications from the British National Formulary and guidance from the National Institute for Health and Care Excellence: a cross-sectional study of UK mediaMargaret McCartney, Rosa Morgan-Young, Frank Sullivan, et al.
Melanoma Research|April 11, 2015
The cost of ipilimumab toxicity: a single-centre analysisNadia Yousaf, Michael Davidson, Emily Goode, et al.
The Journal of Arthroplasty|December 11, 2012
Stiffness after total knee arthroplasty: does component alignment differ in knees requiring manipulation? A retrospective cohort study of 281 patientsPaul Harvie, James Larkin, Matt Scaddan, et al.
The Lancet. Oncology|August 1, 2012
Adjuvant nodal irradiation in melanomaMuhammad Khattak, Martin Gore, James Larkin, et al.
Pageof 42